查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1414304

2024 年免疫血液学全球市场报告

Immunohematology Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，免疫血液学市场规模一直强劲成长。将从2023年的23.4亿美元扩大到2024年的24.9亿美元，复合年增长率为6.3%。过去一段时间的扩张归因于输血科学的进步、血液疾病的流行、血库的扩大、政府在血液安全方面的倡议、外科手术的增加以及对输血相关风险的认识的提高。我是。

人口老化预计将极大促进免疫血液学市场的扩张。老龄化社会的特征是老年人在社会和人口中所占比例不断增加，这就产生了对免疫血液学的需求，以满足与老龄化相关的输血需求，并确保在医疗干预中安全使用血液製品。我是。美国人口普查局报告称，2022年该国的中位数年龄将上升至38.9岁，显示人口正在老化。因此，人口老化是推动免疫血液学市场成长的关键因素。

2023年免疫血液学市场最大的地区是北美。预计亚太地区将成为预测期内全球免疫血液学市场成长最快的地区。免疫血液学市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与抑制因素
    • 市场驱动因素
    • 市场抑制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球免疫血液学市场，依产品、性能及预测细分，2018-2023、2023-2028、2033
  • 分析仪及系统
  • 试剂
  • 全球免疫血液学市场，按技术、性能和预测细分，2018-2023、2023-2028、2033
  • 生物晶片
  • 红血球磁化技术（EMT）
  • 凝胶卡
  • 微孔板
  • 聚合酶炼式反应 (PCR)
  • 全球免疫血液学市场，依疾病、绩效及预测细分，2018-2023、2023-2028、2033
  • 血液相关疾病
  • HIV
  • 肝炎
  • 全球免疫血液学市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 输血前测试
  • 免疫溶血研究
  • 周产期检查
  • 血型表型分析
  • 白血球和血小板的血清学
  • 全球免疫血液学市场，按最终用户细分、绩效和预测，2018-2023、2023-2028、2033
  • 血库
  • 诊断与参考实验室
  • 医院
  • 学术研究所

第 7 章 区域与国家分析

  • 全球免疫血液学市场，按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球免疫血液学市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 免疫血液学市场竞争形势
  • 免疫血液学市场的公司概况
    • Ortho Clinical Diagnostics Inc.
    • Immunocor Inc.
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Grifols SA

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与可能性分析

第35章附录

简介目录
Product Code: r11814

“Immunohematology Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunohematology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunohematology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The immunohematology market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Analyzers And Systems; Reagents
  • 2) By Technology: Biochips; Erythrocyte-Magnetized Technology (Met); Gel Cards; Microplates; Polymerase Chain Reaction (PCR)
  • 3) By Disease: Blood-Related Diseases; HIV; Hepatitis
  • 4) By Application: Pretransfusion Testing; Investigation Of Immune Hemolysis; Perinatal Testing; Blood Group Phenotyping; Leucocyte And Platelet Serology
  • 5) By End User: Blood Banks; Diagnostic And Reference Laboratories; Hospitals; Academic And Research Institutes
  • Companies Mentioned: Ortho Clinical Diagnostics Inc.; Immunocor Inc.; Abbott Laboratories; Siemens Healthineers AG; Grifols S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Immunohematology is a subfield of laboratory medicine that focuses on the study of blood groups and the immune response of the body to foreign substances, particularly in the context of blood transfusions. Immunohematological techniques are employed to identify and address diagnostic issues in patients with hematological conditions, including auto-immune hemolytic anemia.

The main components of immunohematology include analyzers and systems, along with reagents. Analyzers and systems are automated instruments designed for blood typing and antibody screening. Various technologies are utilized in this field, such as biochips, erythrocyte-magnetized technology (EMT), gel cards, microplates, and polymerase chain reaction (PCR). These technologies are applied in the treatment of various diseases such as HIV and hepatitis. The diverse applications encompass pretransfusion testing, investigation of immune hemolysis, perinatal testing, blood group phenotyping, leucocyte and platelet serology. The end-users of immunohematology products include blood banks, diagnostic and reference laboratories, hospitals, as well as academic and research institutes.

The immunohematology market research report is one of a series of new reports from The Business Research Company that provides immunohematology optical components market statistics, including immunohematology optical components industry global market size, regional shares, competitors with a immunohematology optical components market share, detailed immunohematology optical components market segments, market trends and opportunities, and any further data you may need to thrive in the immunohematology optical components industry. This immunohematology optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohematology market size has grown strongly in recent years. It will grow from $2.34 billion in 2023 to $2.49 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The expansion observed in the historical period can be attributed to advancements in blood transfusion science, the prevalence of blood disorders, the expansion of blood banks, government initiatives for blood safety, increased surgical procedures, and heightened awareness of transfusion-related risks.

The immunohematology market size is expected to see strong growth in the next few years. It will grow to $3.04 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The anticipated growth in the forecast period can be attributed to the increasing demand for point-of-care testing, the emergence of novel blood products, the expansion of healthcare infrastructure, genetic testing for blood compatibility, and regulatory support for blood safety. Key trends expected in the forecast period involve the adoption of automation and high-throughput systems, the implementation of molecular blood typing methods, advancements in antibody detection techniques, the promotion of patient blood management programs, the integration of AI in analysis, and the incorporation of telemedicine.

The anticipated rise in the prevalence of hematological disorders is set to drive the growth of the immunohematology market in the foreseeable future. Hematological disorders, affecting blood components such as red blood cells, white blood cells, platelets, and plasma, necessitate the use of immunohematology for safe and effective blood transfusions. This helps prevent transfusion reactions arising from incompatible blood types or the presence of antibodies in the recipient's blood. Immunohematology techniques also play a crucial role in diagnosing and treating diseases impacting the immune system, with potential implications for the hematological system. For instance, Cancer Research UK reported an expected increase in new leukemia cases due to hematological disorders in the UK, rising from approximately 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Thus, the escalating prevalence of hematological disorders is a key driver behind the growth of the immunohematology market.

The aging population is anticipated to contribute significantly to the expansion of the immunohematology market. An aging population, characterized by a growing proportion of elderly individuals within a society or population, creates a demand for immunohematology to address age-related transfusion needs and ensure the safe use of blood products in medical interventions. The United States Census Bureau reported an increase in the country's median age to 38.9 years in 2022, indicating an ongoing trend of population aging. Therefore, the aging population is a significant factor driving the growth of the immunohematology market.

Technological advancements emerge as a prevalent trend in the immunohematology market, with major companies concentrating on innovative technologies to maintain their market standing. For instance, in October 2021, Ortho Clinical Diagnostics launched new capabilities for its Immediate Spin Crossmatch (ISXM) system, enhancing the comprehensive transfusion solution for ORTHO VISION and ORTHO VISION MAX Analyzers. This system streamlines and automates immunohematology testing and processing, particularly in identifying ABO blood type incompatibility during blood transfusions.

Major companies operating in the immunohematology market are innovating by introducing new products such as self-sampling blood collection products to enhance their market profitability. Self-sampling blood collection involves individuals collecting their own blood samples for diagnostic purposes without the need for healthcare professionals. For example, in February 2023, Capitainer launched CapitainerB 50, a self-sampling blood collection device that protects samples from contamination. The microsampling technology employed ensures precise quantitative sampling comparable to conventional pipetting.

In March 2023, Werfen, S.A., a diagnostic care company based in Spain, completed the acquisition of Immucor Inc. for approximately $2 billion. This strategic move aimed to expand Werfen's capabilities in specialized diagnostic testing, particularly within diagnostic solutions. Immucor Inc., a transfusion diagnostics company based in Spain, focuses on providing safe, accessible, and affordable blood tests.

Major companies operating in the immunohematology market report are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Nihon Kohden Corporation, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Harvard bioscience Inc., Cenogenics Corporation, Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Cellnovo Group, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

North America was the largest region in the immunohematology market in 2023. Asia-Pacific is expected to be the fastest growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunohematology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunohematology market includes revenues earned by entities by providing blood banking and transfusion medicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Immunohematology Market Characteristics

3. Immunohematology Market Trends And Strategies

4. Immunohematology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Immunohematology Market Size and Growth

  • 5.1. Global Immunohematology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Immunohematology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Immunohematology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Immunohematology Market Segmentation

  • 6.1. Global Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Analyzers And Systems
  • Reagents
  • 6.2. Global Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biochips
  • Erythrocyte-Magnetized Technology (Emt)
  • Gel Cards
  • Microplates
  • Polymerase Chain Reaction (PCR)
  • 6.3. Global Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Blood-Related Diseases
  • HIV
  • Hepatitis
  • 6.4. Global Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pretransfusion Testing
  • Investigation Of Immune Hemolysis
  • Perinatal Testing
  • Blood Group Phenotyping
  • Leucocyte And Platelet Serology
  • 6.5. Global Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Blood Banks
  • Diagnostic And Reference Laboratories
  • Hospitals
  • Academic And Research Institutes

7. Immunohematology Market Regional And Country Analysis

  • 7.1. Global Immunohematology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Immunohematology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Immunohematology Market

  • 8.1. Asia-Pacific Immunohematology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Immunohematology Market

  • 9.1. China Immunohematology Market Overview
  • 9.2. China Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Immunohematology Market

  • 10.1. India Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Immunohematology Market

  • 11.1. Japan Immunohematology Market Overview
  • 11.2. Japan Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Immunohematology Market

  • 12.1. Australia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Immunohematology Market

  • 13.1. Indonesia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Immunohematology Market

  • 14.1. South Korea Immunohematology Market Overview
  • 14.2. South Korea Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Immunohematology Market

  • 15.1. Western Europe Immunohematology Market Overview
  • 15.2. Western Europe Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Immunohematology Market

  • 16.1. UK Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Immunohematology Market

  • 17.1. Germany Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Immunohematology Market

  • 18.1. France Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Immunohematology Market

  • 19.1. Italy Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Immunohematology Market

  • 20.1. Spain Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Immunohematology Market

  • 21.1. Eastern Europe Immunohematology Market Overview
  • 21.2. Eastern Europe Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Immunohematology Market

  • 22.1. Russia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Immunohematology Market

  • 23.1. North America Immunohematology Market Overview
  • 23.2. North America Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Immunohematology Market

  • 24.1. USA Immunohematology Market Overview
  • 24.2. USA Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Immunohematology Market

  • 25.1. Canada Immunohematology Market Overview
  • 25.2. Canada Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Immunohematology Market

  • 26.1. South America Immunohematology Market Overview
  • 26.2. South America Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Immunohematology Market

  • 27.1. Brazil Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Immunohematology Market

  • 28.1. Middle East Immunohematology Market Overview
  • 28.2. Middle East Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Immunohematology Market

  • 29.1. Africa Immunohematology Market Overview
  • 29.2. Africa Immunohematology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Immunohematology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Immunohematology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Immunohematology Market Competitive Landscape And Company Profiles

  • 30.1. Immunohematology Market Competitive Landscape
  • 30.2. Immunohematology Market Company Profiles
    • 30.2.1. Ortho Clinical Diagnostics Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Immunocor Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens Healthineers AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Grifols S.A.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Immunohematology Market Competitive Benchmarking

32. Global Immunohematology Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Immunohematology Market

34. Immunohematology Market Future Outlook and Potential Analysis

  • 34.1 Immunohematology Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Immunohematology Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Immunohematology Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer